Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema
- PMID: 2536404
- PMCID: PMC303731
- DOI: 10.1172/JCI113934
Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema
Abstract
C1-inhibitor (C1-Inh) is an important inhibitor of the inflammatory response and deficiency of this inhibitor, which may be hereditary or acquired, is associated with recurrent episodes of edema. Recently, an autoimmune form of angioedema has been described that is associated with functional deficiency of C1-Inh and an autoantibody that impedes C1-Inh function. In this report we describe the isolation of C1-Inh from the monocytes and plasma of a patient with autoimmune angioedema and demonstrate that the patient's monocytes secrete structurally and functionally normal C1-Inh, but show that this protein circulates in the patient's plasma in an inactive, structurally altered form. Furthermore, using analytic gel electrophoresis techniques it is demonstrated that the patient's autoantibody facilitates cleavage of normal C1-Inh, by its target proteases, to the same species of C1-Inh that is found circulating in the patient's plasma. This autoantibody facilitated cleavage of normal C1-Inh is apparently a consequence of destabilization of protease/inhibitor complexes. These findings contribute to our understanding of protease/C1-Inh interactions and document important observations on pathogenic mechanisms in autoimmune disease.
Similar articles
-
Unmasking of acquired autoimmune C1-inhibitor deficiency by an angiotensin-converting enzyme inhibitor.Ann Allergy Asthma Immunol. 2001 Apr;86(4):461-4. doi: 10.1016/S1081-1206(10)62496-9. Ann Allergy Asthma Immunol. 2001. PMID: 11345293
-
The acquired C1-INH deficiencies with autoantibodies (AAE type II).Behring Inst Mitt. 1989 Jul;(84):165-72. Behring Inst Mitt. 1989. PMID: 2679532 Review.
-
Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies.J Clin Invest. 1989 Jun;83(6):1794-9. doi: 10.1172/JCI114084. J Clin Invest. 1989. PMID: 2723058 Free PMC article.
-
Polyclonal autoantibodies against C1 inhibitor in a case of acquired angioedema.Ann Allergy Asthma Immunol. 2002 Jun;88(6):632-7. doi: 10.1016/S1081-1206(10)61896-0. Ann Allergy Asthma Immunol. 2002. PMID: 12086372
-
Urticaria, angioedema, and autoimmunity.Clin Lab Med. 1997 Sep;17(3):559-69. Clin Lab Med. 1997. PMID: 9316773 Review.
Cited by
-
Acquired Angioedema in Selected Neoplastic Diseases.Medicina (Kaunas). 2023 Mar 24;59(4):644. doi: 10.3390/medicina59040644. Medicina (Kaunas). 2023. PMID: 37109602 Free PMC article.
-
Mechanism of action of anti-C1-inhibitor autoantibodies: prevention of the formation of stable C1s-C1-inh complexes.Mol Med. 1998 Feb;4(2):119-28. Mol Med. 1998. PMID: 9508789 Free PMC article.
-
The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human.PLoS One. 2010 Aug 18;5(8):e12250. doi: 10.1371/journal.pone.0012250. PLoS One. 2010. PMID: 20805888 Free PMC article.
-
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.J Allergy Clin Immunol. 2004 Sep;114(3 Suppl):S51-131. doi: 10.1016/j.jaci.2004.06.047. J Allergy Clin Immunol. 2004. PMID: 15356535 Free PMC article.
-
Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema.J Asthma Allergy. 2014 Dec 2;7:165-7. doi: 10.2147/JAA.S68548. eCollection 2014. J Asthma Allergy. 2014. PMID: 25506230 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical